DAX 24.955 +0,2%ESt50 6.242 +0,6%MSCI World 4.812 -0,7%Top 10 Crypto 8,21 +1,1%Nas 25.871 +0,2%Bitcoin 54.960 +0,8%Euro 1,1428 +0,1%Öl 77,5 -2,5%Gold 4.108 +0,7%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-PVR: Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

Werte in diesem Artikel
Aktien
Dermapharm Holding SE
46.60 EUR -0.05 EUR -0.11 %
Charts | News | Analysen
Aktie kaufen

EQS Voting Rights Announcement: Dermapharm Holding SE
Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

07.04.2026 / 10:08 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung

Publication of acquisition or disposal in respect of own shares

1. Details of issuer
Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany

2. Names of subsidiary undertakings or third persons
holding directly 3% or more shares, if different from 1.
 

3. Date on which threshold was crossed or reached
02 Apr 2026 

4. Share-position
  Share-position in % total amount of shares issued
Resulting situation 7.99 % 4,299,190
Previous publication % /

5. Details
absolute in %
direct indirect (via subsidiary
or third person, Sec. 71d
para. 1 AktG)		 direct indirect (via subsidiary
or third person, Sec. 71d
para. 1 AktG)
4,299,190 7.99 % %


07.04.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service
Werbung

2304054  07.04.2026 CET/CEST

Aktuelle Dermapharm Aktie News

Werbung

Dermapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dermapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.05.26 Dermapharm Hold Jefferies & Company Inc.
14.05.26 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
31.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.